boi568
Yes, I think that is an accurate description of what we have seen in print and the fact that these various experts have agreed to the main points is, enough for me!
Doc is very familiar with such things, most of us are not. I don't think a 3-4% approval is a fair appraisal though. He raised it from 1-2% which is really not much...
I will stick with: APPROVAL in Europe; and who knows how the FDA will handle the NDA, but if approved in Europe, I think the FDA will also approve.
No one can deny that the price trend is UP with the low in the 3s but has sustained itself from around $5 to now; my bias is for the price to surprise on the upside with the recent dynamics improving and not worsening.
Yes, we do have outside interests attempting to change the psychology to doubt and fear; that's always the case in stock analysis. The payoff from my old eyes will be very large and I hope it works out for my 3 grandchildren who are all stepping into the adult world. One graduated last year and the two others (twins) will finish off their sophomore year at the same university. It would be nice to leave them with an improvement to our world wide crisis in Alzheimer's Disease.
Market Data 
Markets 
AI
